We are live on ! Find out more
CALC icon

CalciMedica
CALC

25 hedge funds and large institutions have $6.27M invested in CalciMedica in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,840% more call options, than puts

Call options by funds: $147K | Put options by funds: $5K

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

0% more funds holding

Funds holding: 25 → 25 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

13% less capital invested

Capital invested by funds: $7.17M → $6.27M (-$905K)

Holders
25
Holders Change
–
Holders Change %
0%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
3
Closed
3
Calls
$147K
Puts
$5K
Net Calls
+$142K
Net Calls Change
-$11K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$150K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$52.6K
3
Jane Street
Jane Street
New York
+$11.6K
4
Morgan Stanley
Morgan Stanley
New York
+$3.03K
5
Brown Advisory
Brown Advisory
Maryland
+$1.26K

Top Sellers

1
BCM
Bridgeway Capital Management
Texas
-$50.6K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$34.3K
3
Two Sigma Investments
Two Sigma Investments
New York
-$19K
4
LCS
Levin Capital Strategies
New York
-$16K
5
UBS Group
UBS Group
Switzerland
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$4.97M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$394K -$34.3K -2,424 -7%
First Manhattan
3
First Manhattan
New York
$274K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$189K +$150K +10,600 +285%
Bank of New York Mellon
5
Bank of New York Mellon
New York
$95K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$62K – – –
BCM
7
Bridgeway Capital Management
Texas
$60K -$50.6K -3,572 -44%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$59K +$52.6K +3,715 +463%
JJ
9
Johnson & Johnson
New Jersey
$47K – – –
State Street
10
State Street
Massachusetts
$33K – – –
Osaic Holdings
11
Osaic Holdings
Arizona
$18K – – –
Brown Advisory
12
Brown Advisory
Maryland
$17K +$1.26K +89 +7%
Northern Trust
13
Northern Trust
Illinois
$15K – – –
Morgan Stanley
14
Morgan Stanley
New York
$11K +$3.03K +214 +33%
Jane Street
15
Jane Street
New York
$11K +$11.6K +818 New
PNC Financial Services Group
16
PNC Financial Services Group
Pennsylvania
$8K – – –
O
17
OrbiMed
New York
$3.92K – – –
Federated Hermes
18
Federated Hermes
Pennsylvania
$2K – – –
BlackRock
19
BlackRock
New York
$1K – – –
BNP Paribas Financial Markets
20
BNP Paribas Financial Markets
France
$107 +$113 +8 New
Two Sigma Investments
21
Two Sigma Investments
New York
– -$19K -1,230 Closed
UBS Group
22
UBS Group
Switzerland
– -$16K -1,127 -99%
LCS
23
Levin Capital Strategies
New York
– -$16K -1,071 Closed
Fidelity Investments
24
Fidelity Investments
Massachusetts
– -$1K -57 Closed
JP Morgan Chase
25
JP Morgan Chase
New York
– +$14 +1 New
1
2

CALC Hedge Fund Activity: Q3 2022 in Review

25 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q3 2022, worth a combined $6.27M — down 13% from $7.17M a quarter earlier.

Fund positioning in CALC was balanced in Q3 2022: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $150K. The largest seller was Bridgeway Capital Management, cutting an estimated $50.6K.

  • 25 institutional investors held CalciMedica (CALC) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $6.27M of CalciMedica stock for Q3 2022, down 13% quarter-over-quarter.
  • 3 funds opened new CalciMedica positions in Q3 2022 and 3 closed out, a net change of 0 holders.
  • The largest CalciMedica buyer in Q3 2022 was Renaissance Technologies, an estimated $150K added.
  • The largest CalciMedica seller in Q3 2022 was Bridgeway Capital Management, an estimated $50.6K sold.

Based on aggregated 13F filings for Q3 2022.